Literature DB >> 25833321

The empirical status of psychodynamic psychotherapy - an update: Bambi's alive and kicking.

Falk Leichsenring1, Frank Leweke, Susanne Klein, Christiane Steinert.   

Abstract

BACKGROUND: The Task Force on Promotion and Dissemination of Psychological Procedures proposed rigorous criteria to define empirically supported psychotherapies. According to these criteria, 2 randomized controlled trials (RCTs) showing efficacy are required for a treatment to be designated as 'efficacious' and 1 RCT for a designation as 'possibly efficacious'. Applying these criteria modified by Chambless and Hollon, this article presents an update on the evidence for psychodynamic therapy (PDT) in specific mental disorders.
METHODS: A systematic search was performed using the criteria by Chambless and Hollon for study selection, as follows: (1) RCT of PDT in adults, (2) use of reliable and valid measures for diagnosis and outcome, (3) use of treatment manuals or manual-like guidelines, (4) adult population treated for specific problems and (5) PDT superior to no treatment, placebo or alternative treatment or equivalent to an established treatment.
RESULTS: A total of 39 RCTs were included. Following Chambless and Hollon, PDT can presently be designated as efficacious in major depressive disorder (MDD), social anxiety disorder, borderline and heterogeneous personality disorders, somatoform pain disorder, and anorexia nervosa. For MDD, this also applies to the combination with pharmacotherapy. PDT can be considered as possibly efficacious in dysthymia, complicated grief, panic disorder, generalized anxiety disorder, and substance abuse/dependence. Evidence is lacking for obsessive-compulsive, posttraumatic stress, bipolar and schizophrenia spectrum disorder(s).
CONCLUSIONS: Evidence has emerged that PDT is efficacious or possibly efficacious in a wide range of common mental disorders. Further research is required for those disorders for which sufficient evidence does not yet exist.

Entities:  

Mesh:

Year:  2015        PMID: 25833321     DOI: 10.1159/000376584

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  7 in total

1.  Further Evidence for Short-Term Psychodynamic Therapy in Major Depressive Disorder.

Authors:  Falk Leichsenring; Christiane Steinert
Journal:  Can J Psychiatry       Date:  2017-01       Impact factor: 4.356

Review 2.  Is Psychoanalysis Still Relevant to Psychiatry?

Authors:  Joel Paris
Journal:  Can J Psychiatry       Date:  2017-01-31       Impact factor: 4.356

Review 3.  Cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy (MT); comparison of three established psychotherapies and possible common neural mechanisms of psychotherapies.

Authors:  Johannes M Dijkstra; Toshiharu Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2021-12-10       Impact factor: 3.850

4.  Long-Term Effectiveness of a Stress Management Intervention at Work: A 9-Year Follow-Up Study Based on a Randomized Wait-List Controlled Trial in Male Managers.

Authors:  Jian Li; Natalie Riedel; Amira Barrech; Raphael M Herr; Birgit Aust; Kathrin Mörtl; Johannes Siegrist; Harald Gündel; Peter Angerer
Journal:  Biomed Res Int       Date:  2017-10-18       Impact factor: 3.411

Review 5.  Depression and psychodynamic psychotherapy.

Authors:  Ângela Ribeiro; João P Ribeiro; Orlando von Doellinger
Journal:  Braz J Psychiatry       Date:  2017-06-12       Impact factor: 2.697

6.  Empirically supported psychodynamic psychotherapy for common mental disorders-An update applying revised criteria: Systematic review protocol.

Authors:  Falk Leichsenring; Allan Abbass; Nikolas Heim; John R Keefe; Patrick Luyten; Sven Rabung; Christiane Steinert
Journal:  Front Psychiatry       Date:  2022-09-15       Impact factor: 5.435

7.  "Gold Standards," Plurality and Monocultures: The Need for Diversity in Psychotherapy.

Authors:  Falk Leichsenring; Allan Abbass; Mark J Hilsenroth; Patrick Luyten; Thomas Munder; Sven Rabung; Christiane Steinert
Journal:  Front Psychiatry       Date:  2018-04-24       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.